ALK-Abelló A/S (AKBLF)
OTCMKTS
· Delayed Price · Currency is USD
26.99
+1.04 (4.01%)
At close: May 30, 2025
ALK-Abelló Employees
ALK-Abelló had 2,753 employees as of December 31, 2024. The number of employees decreased by 71 or -2.51% compared to the previous year.
Employees
2,753
Change (1Y)
-71
Growth (1Y)
-2.51%
Revenue / Employee
$302,279
Profits / Employee
$49,621
Market Cap
6.36B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Tian'an Technology Group | 8 |
| CytoDyn | 9 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
ALK-Abelló News
- 4 weeks ago - ALK-Abelló A/S (AKBLF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - ALK-Abelló A/S 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - ALK-Abelló A/S reports Q1 results - Seeking Alpha
- 6 weeks ago - ARS Pharmaceuticals signs agreement with ALK-Abelló A/S for neffy - Seeking Alpha
- 4 months ago - ALK-Abelló projects 9%-13% revenue growth for 2025 driven by global tablet expansion - Seeking Alpha
- 4 months ago - ALK-Abelló A/S (AKBLF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - ALK-Abelló A/S reports FY results - Seeking Alpha
- 7 months ago - Q3 2024 ALK-Abello A/S Earnings Call Transcript - GuruFocus